Efficacité du traitement de reperfusion au stade aigu de l'infarctus dans la population âgée : données du registre USIK 1995

  title={Efficacit{\'e} du traitement de reperfusion au stade aigu de l'infarctus dans la population {\^a}g{\'e}e : donn{\'e}es du registre USIK 1995},
  author={T Demich{\'e}li and J. P. Cambou and Laurent Vaur and N. Gen{\`e}s and Sylvie Etienne and Micha{\"e}l Angioi and Nicolas Danchin},
  journal={Annales De Cardiologie Et D Angeiologie},
9 Citations
Percutaneous Coronary Interventional Therapy in the 9th Decade of Life
There is a report of percutaneous coronary intervention (PCI) in 12 cases of coronary artery disease among nonagenarians, and the author claims to be the first 1 to report PCI in this age group, and also notes very few reports in the literature.


Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial.
Lower mortality and greater net clinical benefit were seen with accelerated TPA in patients aged < or = 85 years, and the relative superiority of a given thrombolytic regimen cannot be determined.
Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years.
In nationwide clinical practice, thrombolytic therapy for patients >75 years old is unlikely to confer survival benefit and may have a significant survival disadvantage.
A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction.
This trial suggests that angioplasty provides a small-to-moderate, short-term clinical advantage over thrombolytic therapy with t-PA, and should be considered an excellent alternative method for myocardial reperfusion.
A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.
As compared with t-PA therapy for acute myocardial infarction, immediate PTCA reduced the combined occurrence of nonfatal reinfarction or death, was associated with a lower rate of intracranial hemorrhage, and resulted in similar left ventricular systolic function.
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
The findings of this large-scale trial indicate that accelerated t-PA given with intravenous heparin provides a survival benefit over previous standard thrombolytic regimens.
A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction.
Immediate angioplasty after acute myocardial infarction was associated with a higher rate of patency of the infarct-related artery, a less severe residual stenotic lesion, better left ventricular function, and less recurrentMyocardial ischemia andinfarction than was intravenous streptokinase.
Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction : A quantitative review
Based on outcomes at hospital discharge or 30 days, primary angioplasty appears to be superior to thrombolytic therapy for treatment of patients with acute myocardial infarction, with the proviso that success rates for angiopLasty are as good as those achieved in these trials.